Dr. Reddy's Unveils Breakthrough Solution for Acid-Related GI Woes in India

Hyderabad, India – In a significant move set to bring much-needed relief to millions, Dr. Reddy's Laboratories has officially announced the launch of Esomeprazole Magnesium DR Capsules across India. This therapeutic equivalent generic version of Esomeprazole Magnesium DR Capsules will be available in 20 mg and 40 mg strengths, targeting a wide array of acid-related gastrointestinal diseases.

The introduction of this new drug marks a crucial step in Dr.

Reddy's ongoing commitment to making innovative and high-quality medicines accessible to patients throughout India. Acid-related gastrointestinal issues, ranging from persistent heartburn to more severe conditions like peptic ulcers and gastroesophageal reflux disease (GERD), affect a substantial portion of the population, impacting their quality of life daily.

"We are steadfast in our mission to ensure that effective and affordable healthcare solutions reach every corner of the nation," stated M.V.

Ramana, CEO, Branded Markets (India and Emerging Markets), Dr. Reddy's. "The launch of Esomeprazole Magnesium DR Capsules perfectly aligns with our strategic focus on addressing critical healthcare needs and enhancing patient well-being. This product underscores our dedication to providing robust and accessible treatment options."

India's gastrointestinal (GI) segment represents a considerable and growing market, where Esomeprazole has long been recognized as a leading and highly effective molecule for managing acid secretion.

Dr. Reddy's entry into this specific therapeutic area with a high-quality generic version is poised to offer a reliable and cost-effective alternative for patients and healthcare providers alike.

Dr. Reddy's Laboratories Ltd., headquartered in Hyderabad, India, is a globally recognized pharmaceutical company.

Its extensive portfolio encompasses Active Pharmaceutical Ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) products. With a strong presence in major markets like India, USA, Russia & CIS, and Europe, the company focuses on therapeutic areas including oncology, gastrointestinal, cardiovascular, diabetology, pain management, and dermatology.

Driven by a core purpose to provide affordable and innovative medicines for healthier lives, Dr. Reddy's continues to solidify its position as a leader in global healthcare innovation.

The launch of Esomeprazole Magnesium DR Capsules is expected to significantly contribute to improving patient outcomes for those suffering from debilitating acid-related conditions, further cementing Dr.

Reddy's role as a trusted pharmaceutical partner in India's healthcare landscape.